Carbamazepine treatment of bipolar disorder: A retrospective evaluation of naturalistic long-term outcomes

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Chen, Chia Hui ^a   Lin, Shih Ku ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Bipolar disorder; Carbamazepine; Maintenance therapy

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; ATAXIA; BIPOLAR DISORDER; BLURRED VISION; COGNITIVE DEFECT; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; ONSET AGE; RASH; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; WEIGHT GAIN; AGED; ANTHROPOMETRIC PARAMETERS; BIPOLAR I DISORDER; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CLINICAL EVALUATION; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DRUG ERUPTION; DRUG SAFETY; DSM-IV; HAND TREMOR; HOSPITAL ADMISSION; LONG TERM CARE; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CARBAMAZEPINE; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84861333455     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-47     Document Type: Article

References (26)

1. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002, 359(9302):241-247. 10.1016/S0140-6736(02)07450-0, 11812578.
2. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995, 152(11):1635-1640.
3. Thase ME. Maintenance therapy for bipolar disorder. J Clin Psychiatry 2008, 69(11):e32. 10.4088/JCP.1108e32, 19200424.
4. Emrich HM, Dose M, von Zerssen ZD. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 1985, 8(3):243-250. 10.1016/0165-0327(85)90022-9, 3160736.
5. Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry 1994, 164(2):208-214. 10.1192/bjp.164.2.208, 7909713.
6. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol 1978, 2(2):159-175.
7. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr Neurol Jpn 1973, 27(4):283-297.
8. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980, 137(7):782-790.
9. Lenzi A, Lazzerini F, Grossi E, Massimetti G, Placidi GF. Use of carbamazepine in acute psychosis: a controlled study. J Int Med Res 1986, 14(2):78-84.
10. Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987, 48(3):89-93.
11. Yang YY, Deng HC, Wang BH. The increasing use of anticonvulsants in prophylactic treatment of bipolar disorder. Psychiatry Clin Neurosci 1998, 52(4):429-431. 10.1046/j.1440-1819.1998.00405.x, 9766693.
12. Weisler RH, Keck PE, Swann AC, Cutler AJ, Ketter TA, Kalali AH. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005, 66(3):323-330. 10.4088/JCP.v66n0308, 15766298.
13. Weisler RH, Kalali AH, Ketter TA. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004, 65(4):478-484. 10.4088/JCP.v65n0405, 15119909.
14. Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992, 85(2):114-118. 10.1111/j.1600-0447.1992.tb01453.x, 1543034.
15. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997, 58(11):470-478. 10.4088/JCP.v58n1102, 9413412.
16. Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, et al. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J Affect Disord 2007, 104(1-3):185-190.
17. Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 1999, 14(5):277-281.
18. Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991, 48(10):915-921. 10.1001/archpsyc.1991.01810340047006, 1929761.
19. Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology (Berl) 1981, 73(1):95-96.
20. Dardennes R, Even C, Bange F, Heim A. Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. Br J Psychiatry 1995, 166(3):378-381. 10.1192/bjp.166.3.378, 7788131.
21. Akiskal HS, Fuller MA, Hirschfeld RM, Keck PE, Ketter TA, Weisler RH. Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data. CNS Spectr 2005, 10(6):suppl-11.
22. Bowden CL. Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disord 2009, 11(Suppl 2):20-33.
23. Calabrese JR, Rapport DJ, Shelton MD, Kimmel SE. Evolving methodologies in bipolar disorder maintenance research. Br J Psychiatry Suppl 2001, 41:s157-s163.
24. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000, 42(Suppl 1):2-10.
25. Keck PE, McElroy SL. Carbamazepine and valproate in the maintenance treatment of bipolar disorder. J Clin Psychiatry 2002, 63(Suppl 10):13-17.
26. Ketter TA, Kalali AH, Weisler RH. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004, 65(5):668-673. 10.4088/JCP.v65n0511, 15163253.